PROTAC AR-V7 degrader-1
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-145479-5MG | 5 mg | 760,00 | Add | |
| HY-145479-1ML | 10mM/1mL | 1'059,00 | Add | |
| HY-145479-10MG | 10 mg | 1'217,00 | Add | |
| HY-145479-25MG | 25 mg | 2'357,00 | Add | |
| HY-145479-50MG | 50 mg | 3'814,00 | Add | |
| HY-145479-100MG | 100 mg | 6'094,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
PROTAC AR-V7 degrader-1 (Compound 6) is a potent, orally bioavailable and selective AR-V7 degrader with the DC50 of 0.32 µM by recruiting VHL E3 ligase to Androgen receptor (AR) DNA binding domain (DBD) binder. PROTAC AR-V7 degrader-1 exhibits activity against 22Rv1 cell-line expressing AR-V7 with the EC50 of 0.88 µM[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, PROTAC,Vitamin D Related/Nuclear Receptor |
| Format | Solubility: DMSO : 110 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.34% |
| Molecular Formula | C41H52N6O6S2 |
| Molecular Weight | 789.02 |
| CAS-Number | 2767440-24-2 |
| Storage Conditions | -20°C (Powder, protect from light) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Blue Ice |
| Material Safety Data Sheet | Download PDF |
